[British Medical Journal Publishing Group 22nd EAHP Congress 22â24 March 2017 Cannes, France - ()] Clinical pharmacy - CP-197â Protocol compliance in the treatment of hypercholesterolaemia with protein convertase SUBTILISIN-LIKE/KEXIN type 9 inhibitors (PCSK9 inhibitors)
Aguilar-Valle, E, Estaun-Martinez, C, Moya-Carmona, I, Pedrosa-Ruiz, M, Mora-Santiago, R, Fernández-Ovies, JMDOI:
10.1136/ejhpharm-2017-000640.195
File:
PDF, 51 KB